GREATER CHINA Sector Internet Navigating headwinds and uncovering opportunities upon tariff pressures. INDONESIA Update Erajaya Swasembada (ERAA IJ/BUY/Rp348/Target: Rp480) Iphone 16 series to be available in 2Q25. Maintain BUY. MALAYSIA Update Matrix Concepts Holdings (MCH MK/BUY/RM1.27/Target: RM1.66) We view the RPT deal as fair and strategic as the acquisition allows Matrix to see faster ro...
The tone at BCH’s 4Q24 analyst meeting was positive. We expect BCH to show strong growth in 2025, fuelled by the reopening of Kasemrad Pathumthani, operational improvement from three new hospitals and growth of patient volume driven by SC+. We should see a mild earnings growth in 1Q25 from the positive impact of the influenza outbreak, which should be able to offset the impact of the absence of Kuwaiti patients. Maintain BUY. Target price: Bt20.00.
GREATER CHINA Sector Automobile: Weekly: PV sales rebound wow; smart EVs to benefit from policy support. Maintain MARKET WEIGHT on the sector. Top BUYs: Geely, CATL, Fuyao and Desay SV. Results JD.com (9618 HK/BUY/HK$179.00/Target: HK$220.00): 4Q24: Strong earnings beat; resilient top-line bolstered by trade-in programme. JD Logistics, Inc (2618 HK/BUY/HK$15.46/Target: HK$22.00): 2024: Results broadly in line; revenue growth to accelerate in 2025. Maintain BUY. INDONESIA Initiate Coverage Harum...
KEY HIGHLIGHTS Results Bangkok Chain Hospital (BCH TB/BUY/Bt15.70/Target: Bt20.00) 4Q24: Weaker-than-expected earnings. Central Pattana (CPN TB/BUY/Bt49.25/Target: Bt79.30) 4Q24: Earnings exceeded estimates; record dividend announced. Electricity Generating PCL (EGCO TB/BUY/Bt96.25/Target: Bt120.00) 4Q24: Results in line with good outlook. Update LPN Development (LPN TB/SELL/Bt2.18/Target: Bt1.60) Unexciting business plan for...
GREATER CHINA Economics PMI: Uptick in February. Sector Macau Gaming: Feb 25 GGR beat thanks to tail-end effect post CNY; switch top pick to Galaxy. Results New World Development (17 HK/HOLD/HK$4.82/Target: HK$4.45): 1HFY25: Net loss in line with profit warning and primarily caused by inventory impairment; refinancing progress to be the key. Xinyi Solar Holdings (968 HK/HOLD/HK$3.29/Target: HK$3.60): 2024: Below expectations; industry coordination and production discipline crucial to restore mar...
BCH is expected to report a net profit of Bt197m in 4Q24 (-53.8% yoy, -56.5% qoq). The weak earnings should be caused by the anticipated negative AdjRW>2 impact and the rising expenses incurred by the new cancer centre and the partial reopening of a hospital. We are positive on BCH as: a) there should be no more AdjRW>2 rate cut going forward, b) the cancer centre is ramping up well, and c) the influenza outbreak is happening earlier this year. Maintain BUY. Target price: Bt20.00.
KEY HIGHLIGHTS Results Berli Jucker (BJC TB/BUY/Bt22.40/Target: Bt28.00) 4Q24: Results in line; core earnings improvement in 2025 after two-year drop. Star Petroleum Refining (SPRC TB/BUY/Bt5.35/Target: Bt9.00) 4Q24: Results in line; good time to accumulate. Update Bangkok Chain Hospital (BCH TB/BUY/Bt15.00/Target: Bt20.00) Weak earnings in 4Q24 due to the last AdjRW>2 rate cut. Stecon Group (STECON TB/BUY/Bt3.96/Target: Bt5.65) Expect net loss in 4Q24; remain...
GREATER CHINA Sector Dairy: Retail demand remains weak; price recovery and healthier inventories to drive shipment normalisation. Healthcare: Outperformers empowered by AI revolution. INDONESIA Update Champ Resto Indonesia (ENAK IJ/BUY/Rp585/Target: Rp740): 2025 revenue to grow 16% yoy; more conservative on 4Q24 performance. Maintain BUY. MALAYSIA Results Duopharma Biotech (DBB MK/BUY/RM1.28/Target: RM1.39): 4Q24: Largely delivers on earnings. Public sector sales anchor growth while margins im...
GREATER CHINA Economics PMI A strong rebound for non-manufacturing PMI. Sector Macau Gaming Dec 24 GGR below expectations; expect 2025 GGR to recover to 82% of 2019’s level. INDONESIA Update Mitra Keluarga Karyasehat (MIKA IJ/BUY/Rp2,540/Target: Rp3,300) Expect a double-digit earnings growth in 2025 MALAYSIA Sector Heal...
The tone from the analyst meeting for reviewing BCH’s 3Q24 earnings was neutral. We are seeing positives such as the decent earnings growth and the favourable conclusion of the AdjRW>2 rate for next year. However, the reduction of AdjRW>2 for this year is still a potential downside. We are optimistic about BCH, as growth from SSO patients is expected to be strong next year, with several hospitals reopening after renovations. Maintain BUY. Target price: Bt20.00.
GREATER CHINA Economics PMI Manufacturing PMI Edges Up, Non-Manufacturing Still Under Pressure. Sector Macau Gaming Nov 24 GGR Down 11% Mom After A Strong Golden Week; More Policies To Support Macau Visitations. Results Meituan (3690 HK/BUY/HK$168.70/Target: HK$222.00) 3Q24: Solid earnings beat; 4Q24 out...
BCH reported a net profit of Bt453m in 3Q24 (+2.9% yoy, +63.6% qoq) which is in line with our and consensus forecasts. BCH did a decent job in compensating the decline in IPD revenue caused by the absence of Kuwait patients and posted a soft yoy revenue growth in 3Q24. We are optimistic about BCH as the AdjRW>2 rate is likely to be settled in a way that benefits BCH, and there is clear potential for growth from the new cancer centre. Maintain BUY. Target price: Bt20.00.
KEY HIGHLIGHTS Results Amata Corporation (AMATA TB/BUY/Bt23.50/Target: Bt35.00) 3Q24: Net income missed expectations but still skyrocketed yoy and qoq. Bangkok Chain Hospital (BCH TB/BUY/Bt16.10/Target: Bt20.00) 3Q24: Mild growth. Central Pattana (CPN TB/BUY/Bt60.00/Target: Bt84.00) 3Q24: Results in line; well-positioned to close 2024 with a new record high. Central Plaza Hotel (CENTEL TB/SELL/Bt33.00/Target: Bt47.00) 3Q24: Better-than-expect...
We expect BCH to report a net profit of Bt451m in 3Q24 (+2.3% yoy, +62.7% qoq). The main contributor is the increase of OPD patients during the rainy season. Going forward, we are optimistic on BCH as the conclusion of the AdjRW>2 rate issue is likely to be beneficial for BCH, and there is also visible upside from the new cancer centre. Maintain BUY. Target price: Bt20.00.
KEY HIGHLIGHTS Strategy Impact from Trump’s Policies Foresee a robust outlook for the industrial estate and electronics sectors due to the US-China trade war. Our top picks are AMATA, BANPU, DELTA, STGT and WHA. Results PTT Global Chemical (PTTGC TB/HOLD/Bt26.25/Target: Bt24.50) 3Q24: Net loss of Bt19.3b due to huge impairment loss. Quality Houses (QH TB/HOLD/Bt1.85/Target: Bt1.82) 3Q24: In l...
BCH’s operations have normalised after experiencing earnings fluctuations during the COVID-19 outbreak. Management has revised down the revenue growth guidance for 2024 as a result of pressure from several factors. However, we are cautiously optimistic on BCH as there is a huge upside to the stock if it is able to become an operator of choice for Kuwait patients. Upgrade to BUY. Target price: Bt19.00.
GREATER CHINA Strategy Alpha Picks: September Conviction Calls: We expect an improving operating performance among selected companies in September, and add AIA, COLI, Desay SV, Galaxy Entertainment, Meituan, Ping An and TUL to our BUY list and add Li Auto as a SELL. Update Shenzhou International Group Holdings (2313 HK/BUY/HK$62.55/Target: HK$96.50): Shenzhou NDR Takeaways: Expect 10% volume growth and a flat ASP in 2H24. INDONESIA Update Bank Rakyat Indonesia (BBRI IJ/HOLD/Rp5,100/Target: Rp5,...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.